Author Archive: Roy Zwahlen

Roy Zwahlen

Roy is Associate Counsel at BIO and the main contributor for Patently Biotech. He is a lawyer by training, with a background in international and national politics. He grew up in the developing world and believes that innovation can and does solve many of the world’s problems. Because of this, his work focuses on creating a worldwide policy environment that fosters innovation in the biotechnology sector to prevent and cure diseases such as HIV, to increase crop yields to feed more people, and to decrease the harmful effects of industry on the environment. Roy spends his free time keeping up with his three kids, a wife that knows everything (no joke), and serving in his church and broader community. Learn more about Roy from his Linkedin Profile.

Latest Posts

For July 4: Let’s Thank the Inventors

My hope for America this July 4? I hope, in 100 years, the response time to human and environmental suffering will be immediate. Until that day arrives (thanks to scientific breakthroughs funded by individual citizens) — let’s thank our scientists, investors, and inventors who work and play around us.

Finally, let’s also thank the founding fathers for knowing America’s innovative potential without seeing it for themselves.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Twitter Twang: July 1st

Twitter Twang: July 1st

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags:

Twitter Twang: June 30th

Here’s this morning’s Twitter Twang!

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags:

Holman: Follow-on Biologics Bill Threatens Innovation By Weakening Patent Rights

Chris Holman, Professor at the University of Missouri-Kansas City School of Law and author of Holman’s Biotech IP Blog, recently posted a great summary of the patent provisions in the follow-on biologics bill currently under consideration in Congress.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags:

Twitter Twang: June 29th

a summary of Twitter-derived biotechnology news, inspired by hardworking Twitterers

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: